Literature DB >> 18830258

PET imaging of T cells derived from umbilical cord blood.

H Singh, A M Najjar, S Olivares, R Nishii, U Mukhopadhyay, M Alauddin, P R Manuri, H Huls, D A Lee, G Dotti, C Bollard, P J Simmons, E J Shpall, R E Champlin, J G Gelovani, L J N Cooper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18830258      PMCID： PMC5108177          DOI： 10.1038/leu.2008.256

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

1.  Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy.

Authors:  Lisa Marie Serrano; Timothy Pfeiffer; Simon Olivares; Tontanai Numbenjapon; Jennifer Bennitt; Daniel Kim; David Smith; George McNamara; Zaid Al-Kadhimi; Joseph Rosenthal; Stephen J Forman; Michael C Jensen; Laurence J N Cooper
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

2.  Molecular PET imaging of HSV1-tk reporter gene expression using [18F]FEAU.

Authors:  Suren Soghomonyan; Amin Hajitou; Roberto Rangel; Martin Trepel; Renata Pasqualini; Wadih Arap; Juri G Gelovani; Mian M Alauddin
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

3.  Combining adoptive cellular and immunocytokine therapies to improve treatment of B-lineage malignancy.

Authors:  Harjeet Singh; Lisa Marie Serrano; Timothy Pfeiffer; Simon Olivares; George McNamara; David D Smith; Zaid Al-Kadhimi; Stephen J Forman; Stephen D Gillies; Michael C Jensen; David Colcher; Andrew Raubitschek; Laurence J N Cooper
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

4.  Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography.

Authors:  J G Tjuvajev; N Avril; T Oku; T Sasajima; T Miyagawa; R Joshi; M Safer; B Beattie; G DiResta; F Daghighian; F Augensen; J Koutcher; J Zweit; J Humm; S M Larson; R Finn; R Blasberg
Journal:  Cancer Res       Date:  1998-10-01       Impact factor: 12.701

5.  T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect.

Authors:  Laurence J N Cooper; Max S Topp; Lisa Marie Serrano; Sergio Gonzalez; Wen-Chung Chang; Araceli Naranjo; Christine Wright; Leslie Popplewell; Andrew Raubitschek; Stephen J Forman; Michael C Jensen
Journal:  Blood       Date:  2002-10-10       Impact factor: 22.113

6.  Monitoring the efficacy of adoptively transferred prostate cancer-targeted human T lymphocytes with PET and bioluminescence imaging.

Authors:  Konstantin Dobrenkov; Malgorzata Olszewska; Yury Likar; Larissa Shenker; Gertrude Gunset; Shangde Cai; Nagavarakishore Pillarsetty; Hedvig Hricak; Michel Sadelain; Vladimir Ponomarev
Journal:  J Nucl Med       Date:  2008-06-13       Impact factor: 10.057

7.  Imaging immune response in vivo: cytolytic action of genetically altered T cells directed to glioblastoma multiforme.

Authors:  Jelena Lazovic; Michael C Jensen; Evette Ferkassian; Brenda Aguilar; Andrew Raubitschek; Russell E Jacobs
Journal:  Clin Cancer Res       Date:  2008-06-15       Impact factor: 12.531

8.  HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia.

Authors:  C Bonini; G Ferrari; S Verzeletti; P Servida; E Zappone; L Ruggieri; M Ponzoni; S Rossini; F Mavilio; C Traversari; C Bordignon
Journal:  Science       Date:  1997-06-13       Impact factor: 47.728
  8 in total
  8 in total

1.  Imaging of Sleeping Beauty-Modified CD19-Specific T Cells Expressing HSV1-Thymidine Kinase by Positron Emission Tomography.

Authors:  Amer M Najjar; Pallavi R Manuri; Simon Olivares; Leo Flores; Tiejuan Mi; Helen Huls; Elizabeth J Shpall; Richard E Champlin; Nashaat Turkman; Vincenzo Paolillo; Jason Roszik; Brian Rabinovich; Dean A Lee; Mian Alauddin; Juri Gelovani; Laurence J N Cooper
Journal:  Mol Imaging Biol       Date:  2016-12       Impact factor: 3.488

Review 2.  Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor.

Authors:  Bipulendu Jena; Gianpietro Dotti; Laurence J N Cooper
Journal:  Blood       Date:  2010-05-03       Impact factor: 22.113

3.  Infusing CD19-directed T cells to augment disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignancies.

Authors:  Partow Kebriaei; Helen Huls; Bipulendu Jena; Mark Munsell; Rineka Jackson; Dean A Lee; Perry B Hackett; Gabriela Rondon; Elizabeth Shpall; Richard E Champlin; Laurence J N Cooper
Journal:  Hum Gene Ther       Date:  2012-01-17       Impact factor: 5.695

Review 4.  A new approach to gene therapy using Sleeping Beauty to genetically modify clinical-grade T cells to target CD19.

Authors:  Harjeet Singh; Helen Huls; Partow Kebriaei; Laurence J N Cooper
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

5.  Imaging of genetically engineered T cells by PET using gold nanoparticles complexed to Copper-64.

Authors:  Parijat Bhatnagar; Zheng Li; Yoonsu Choi; Jianfeng Guo; Feng Li; Daniel Y Lee; Matthew Figliola; Helen Huls; Dean A Lee; Tomasz Zal; King C Li; Laurence J N Cooper
Journal:  Integr Biol (Camb)       Date:  2013-01       Impact factor: 2.192

Review 6.  Chimeric antibody receptors (CARs): driving T-cell specificity to enhance anti-tumor immunity.

Authors:  Partow Kebriaei; Susan S Kelly; Pallavi Manuri; Bipulendu Jena; Rineka Jackson; Elizabeth Shpall; Richard Champlin; Laurence J N Cooper
Journal:  Front Biosci (Schol Ed)       Date:  2012-01-01

7.  Tumor lysing genetically engineered T cells loaded with multi-modal imaging agents.

Authors:  Parijat Bhatnagar; Mian Alauddin; James A Bankson; Dickson Kirui; Payam Seifi; Helen Huls; Dean A Lee; Aydin Babakhani; Mauro Ferrari; King C Li; Laurence J N Cooper
Journal:  Sci Rep       Date:  2014-03-28       Impact factor: 4.379

Review 8.  Advancing Immune and Cell-Based Therapies Through Imaging.

Authors:  Vladimir Ponomarev
Journal:  Mol Imaging Biol       Date:  2017-06       Impact factor: 3.488
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.